A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.
Jiang SS, Tang Y, Zhang YJ, Weng DS, Zhou ZG, Pan K, Pan QZ, Wang QJ, Liu Q, He J, Zhao JJ, Li J, Chen MS, Chang AE, Li Q, Xia JC.
Jiang SS, et al. Among authors: zhou zg.
Oncotarget. 2015 Dec 1;6(38):41339-49. doi: 10.18632/oncotarget.5463.
Oncotarget. 2015.
PMID: 26515587
Free PMC article.
Clinical Trial.